Exam (elaborations) NURS 6521 WEEK 9 ADVANCED PHARMACOLOGY
A male patient is receiving rituximab therapy for non-Hodgkin’s lymphoma. Which of the following would be a priority nursing intervention to reduce the risk for cytotoxicity and tumor lysis syndrome? An older adult woman has been diagnosed with acute lymphoblastic leukemia (ALL) and her care team has identified potential benefits of imatinib. Which of the following characteristics of this patient’s current health status may preclude the use of imatinib? A 60-year-old patient experienced a sudden onset of chest pain and shortness of breath and was subsequently diagnosed with a pulmonary embolism in the emergency department. The patient has been started on an intravenous heparin infusion. How does this drug achieve therapeutic effect?
Written for
- Institution
- Walden University
- Course
- NURS 6521 WEEK 9 ADVANCED PHARMACOLOGY
Document information
- Uploaded on
- January 10, 2022
- File latest updated on
- January 10, 2022
- Number of pages
- 5
- Written in
- 2021/2022
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
-
a male patient is receiving rituximab therapy for non hodgkin’s lymphoma which of the following would be a priority nursing intervention to reduce the risk for cytotoxicity and tumor lysis syndrome
